Calliditas
2 known investors
Calliditas develops novel therapeutics for orphan indications, with an initial focus on renal and hepatic rare diseases. Its products include TARPEYO (budesonide) delayed release capsules and Kinpeygo.
BiotechHealthtech
Investors Β· 2
Frequently asked questions
- What does Calliditas do?
- Calliditas develops novel therapeutics for orphan indications, with an initial focus on renal and hepatic rare diseases. Its products include TARPEYO (budesonide) delayed release capsules and Kinpeygo.
- Who are Calliditas's investors?
- Calliditas's investors include Industrifonden, Sofinnova Partners.